Update research from QuotedData

RNS Number : 6349T
Pacific Horizon Investment Tst PLC
25 November 2021
 

Pacific Horizon - Update research from QuotedData

 

25th November 2021

 

Blistering performance

 

Since we last published in January of this year, Pacific Horizon (PHI) has continued with its trend of exceptional outperformance of both its Asia Pacific peer group (where it is comfortably the top-performing trust) and the various indices that it benchmarks itself against.

 

PHI, with its strong focus on growth, benefitted from a high allocation to technology stocks in the aftermath of the pandemic. However, more recently, the trust has benefitted from timely decisions to reduce its high exposure to China, prior to the various regulatory clampdowns seen this year, reallocating the proceeds mostly to India, a market that has performed strongly year to date.

 

Reflecting this, PHI continues to trade at a decent premium to net asset value (NAV) and has been issuing a significant amount of stock. Despite this incredible performance, PHI's manager continues to see strong growth potential for the stocks in PHI's portfolio and is genuinely enthused about the prospects for these companies.

 

Full research:

 

https://quoteddata.com/research/pacific-horizon-blistering-performance-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on Pacific Horizon Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA
123a Kings Road | London SW3 4PL
Tel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com  

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABXBDBDUDDGBU
UK 100

Latest directors dealings